Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1248 Neoplasms 1053 Carcinoma, Non-Small-Cell Lung 861 Prostatic Neoplasms 703 Colorectal Neoplasms 618 Lung Neoplasms 586 Neoplasm Metastasis 446 Multiple Myeloma 427 Leukemia, Myeloid, Acute 403 Pancreatic Neoplasms 377 Ovarian Neoplasms 370 Melanoma 324 Carcinoma, Hepatocellular 293 Recurrence 282 Squamous Cell Carcinoma of Head and Neck 277 Brain Neoplasms 274 Glioblastoma 251 Head and Neck Neoplasms 249 Stomach Neoplasms 239 Carcinoma, Renal Cell 231 Precursor Cell Lymphoblastic Leukemia-Lymphoma 230 Lymphoma 229 Triple Negative Breast Neoplasms 219 Hematologic Neoplasms 214 Endometrial Neoplasms 213 Urinary Bladder Neoplasms 202 Lymphoma, Non-Hodgkin 198 Uterine Cervical Neoplasms 194 Sarcoma 192 Glioma 190

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hormone Receptor Positive Breast Cancer × 90 days × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡